MedPath

Does Galactooligosaccharide Enhance Nutrient Availability

Not Applicable
Recruiting
Conditions
Exogenous Carbohydrate Oxidation
Interventions
Dietary Supplement: Placebo
Dietary Supplement: Bimuno Daily
Registration Number
NCT05742516
Lead Sponsor
University of Bath
Brief Summary

Current evidence suggests that the amount of ingested carbohydrate that we can use for energy during exercise is limited by absorption levels in the gut. Thus, strategies to increase the amount of ingested carbohydrate our body can use are of great interest.

Recent evidence has shown we may be able to use more of the ingested carbohydrate during exercise when supplementing with probiotics ("good bacteria for our gut). It is currently unknown whether the food for these "good" bacteria (known as prebiotics) can induce a similar effect. Therefore, the purpose of this study is to understand if supplementation with the prebiotic Galactooligosaccharide (onwards referred to as BIMUNO®) can increase the use of ingested carbohydrate during exercise. We also aim to understand if BIMUNO® can enhance the availability of other nutrients, such as vitamins and minerals.

Participant will attend 8 laboratory sessions at the University of Bath. The first session is a screening visit lasting no more than 30 minutes. This can take place online, over the phone, or in-person, and the remaining 7 sessions will take place in a University of Bath laboratory. The next session is preliminary testing and familiarisation (approx. 2-2.5 hours). The remaining 6 visits (4 exercise trials \& 2 baseline sample collection visits) will be split across 3 main blocks of the study, each lasting 28 days. Following preliminary testing, you will be randomised into supplementing with either BIMUNO®, or placebo. Block 1 will then begin with you attending the laboratory for a baseline sample collection visit, after which you will begin supplementation for the next 28 days. After this 28-day period, you will complete two exercise trials (details below). The ambient temperature in these trials (separated by \>3 days) will differ (20 \& 35˚C) and will occur in a random order. The second block (termed the 'washout' period) will be a 28-day period where you will take neither BIMUNO® nor the placebo. The third block will then commence and will be identical to block 1 - the only difference being you will take the alternative supplement.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Regular exerciser - defined as participating in at least 30 mins of structured exercise at least 3 times per week
  • Able to complete two hours of moderate intensity cycling
  • Aged 18-60 years
Exclusion Criteria
  • Use of products marketed as prebiotics, probiotics or synbiotics within 4 weeks prior to study entry (e.g. Yakult, Actimel, Activia, VSL#3, Kefir). Regular cheese or yogurt containing lactic acid bacteria are not an exclusion criterion.
  • Systemic antibiotic or antimycotic treatment within 4 weeks prior to study entry.
  • Following diets likely to affect study outcomes: e.g. low FODMAP, KETO/high-fat, gluten free/coeliac, paleo, weight loss, caloric restriction, low-carb, 5:2/whole day energy restriction, Atkins/high-protein, sugar-free, single-food, juicing/any day of juicing, any other restriction diet (e.g. very low calory), or vegan diets (GOS is derived from cow's milk).
  • Changes in diet, supplement use or medication likely to affect study outcomes within 2 months prior to study entry or planned during the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboMaltodextrin powder
GOSBimuno DailyGalactooligosaccharide consumption through the prebiotic product Bimuno.
Primary Outcome Measures
NameTimeMethod
Exogenous carbohydrate oxidation rate120 minutes

amount of ingested carbohydrate used for energy within the body. measures in grams per minute and is calculated from breath samples

Secondary Outcome Measures
NameTimeMethod
Whole-body fat oxidation rate120 minutes

measured from breath samples. unit is grams per minute

Plasma NEFA concentrations120 minutes

measured from blood samples in micromoles per litre

Blood lactate concentrations120 minutes

measured from blood samples in millimoles per litre

Plasma zinc concentration28 days

measured from blood samples. unit is micrograms per decilitre

Plasma ferritin concentration28 days

measured from blood samples. unit is micrograms per litre

Plasma vitamin B1 concentration28 days

measured from blood samples. unit is micrograms per decilitre

Haemoglobin concentration120 minutes

measured from blood samples. grams per decilitre

Haematocrit120 minutes

measured from blood samples. unit is percentage of red blood cells in blood

Plasma intestinal fatty acid binding protein concentration120 minutes

measured from blood samples. unit is nanograms per microlitre

Subjective scale: Gas120 minutes

0-10 scale (0- no discomfort, 10- very severe discomfort)

Endogenous carbohydrate oxidation rate120 minutes

measured from breath samples. unit is grams per minute

Whole-body carbohydrate oxidation rate120 minutes

measured from breath samples. unit is grams per minute

Blood glucose concentrations120 minutes

measured from blood samples in millimoles per litre

Plasma insulin concentrations120 minutes

measured from blood samples in picomoles per litre

Urinary calcium/creatinine ratio28 days

measured from urine sample - ratio of milligrams per decilitre of calcium to milligrams per decilitre

Plasma vitamin B6 concentration28 days

measured from blood samples. unit is micrograms per litre

Plasma vitamin E concentration28 days

measured from blood samples. unit is micrograms per millilitre

Subjective scale: Regurgitation120 minutes

0-10 scale (0- no discomfort, 10- very severe discomfort)

Subjective scale: Nausea120 minutes

0-10 scale (0- no discomfort, 10- very severe discomfort)

Subjective scale: Urge to Defecate120 minutes

0-10 scale (0- no discomfort, 10- very severe discomfort)

Thermal Sensation120 minutes

-4 to +4 scale. -4 very cold, 0 neutral, +4 very hot

Plasma 25-hydroxyvitamin D concentration28 days

measured from blood samples. unit is nanomoles per litre

Plasma vitamin C concentration28 days

measured from blood samples. unit is micromoles per litre

Subjective scale: Fullness120 minutes

0-10 scale (0- no discomfort, 10- very severe discomfort)

Thermal Comfort120 minutes

-4 to +4 scale. -4 very uncomfortable, 0 just comfortable, +4 very comfortable

Subjective scale: Cramps120 minutes

0-10 scale (0- no discomfort, 10- very severe discomfort)

Rating of Perceived Exertion120 minutes

Borg scale: 6-20. 6- very light, 20- extremely hard

Skin temperature120 minutes

measured via four temperature sensors. locations: chest, bicep, quadricep and gastrocnemius

Core temperature120 minutes

measured via rectal probe

Heart rate120 minutes

measured via polar heart rate device placed on chest via strap

Trial Locations

Locations (1)

University of Bath

🇬🇧

Bath, Bath And NE Somerset, United Kingdom

University of Bath
🇬🇧Bath, Bath And NE Somerset, United Kingdom
Adam Collins
Contact
07710611694
ac3413@bath.ac.uk
Adam Collins Collins, MSc
Principal Investigator
Javier Gonzalez, PhD
Principal Investigator
© Copyright 2025. All Rights Reserved by MedPath